T cell-based immunotherapy of metastatic renal cell carcinoma: modest success and future perspective.
(2009)
Journal Article
Shablak, A., Hawkins, R., Rothwell, D., & Elkord, E. (2009). T cell-based immunotherapy of metastatic renal cell carcinoma: modest success and future perspective. Clinical Cancer Research, 15(21), 6503-6510. https://doi.org/10.1158/1078-0432.CCR-09-1605
Metastatic renal cell carcinoma (MRCC) remains a challenging malignancy to treat. Cancer immunotherapies have been extensively explored in melanoma and RCC as they poorly respond to conventional cytotoxic agents but show responses to a variety of imm... Read More about T cell-based immunotherapy of metastatic renal cell carcinoma: modest success and future perspective..